Cargando…

Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance

BACKGROUND: Neonatal sepsis is a serious bacterial infection of neonates, globally killing up to 680 000 babies annually. It is frequently complicated by antimicrobial resistance, particularly in low- and middle-income country (LMIC) settings with widespread resistance to the WHO’s recommended empir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darlow, Christopher A., Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Kolamunnage-Dona, Ruwanthi, Da Costa, Renata M A, Ellis, Sally, Franceschi, François, Sharland, Mike, Neely, Michael, Piddock, Laura J. V., Das, Shampa, Hope, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047679/ https://www.ncbi.nlm.nih.gov/pubmed/35170719 http://dx.doi.org/10.1093/jac/dkac038

Ejemplares similares

Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
por: Darlow, Christopher A, et al.
Publicado: (2022)

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria
por: Darlow, Christopher A., et al.
Publicado: (2021)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2021)

Correction to: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2022)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales—authors’ response
por: Darlow, Christopher A, et al.
Publicado: (2022)

Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease
por: Hope, William W., et al.
Publicado: (2017)

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response
por: Kovanda, Laura L., et al.
Publicado: (2017)

Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus
por: Negri, Clara E, et al.
Publicado: (2018)

Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia
por: Lee, Chen-Hsiang, et al.
Publicado: (2018)

IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis
por: Kane, Zoe, et al.
Publicado: (2021)

Evaluating statistical characteristics of biomarker-guided trial designs
por: Antoniou, Miranta, et al.
Publicado: (2015)

Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials
por: Powney, Matthew, et al.
Publicado: (2013)

Adjusting for informative missing outcome data in clinical trials with longitudinal study designs
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2013)

Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload
por: Obiero, Christina W, et al.
Publicado: (2022)

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2016)

Modelling variable dropout in randomised controlled trials with longitudinal outcomes: application to the MAGNETIC study
por: Kolamunnage-Dona, Ruwanthi, et al.
Publicado: (2016)

Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2016)

Correction to: joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2018)

Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1
por: Antoniou, Miranta, et al.
Publicado: (2018)

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19
por: Antoniou, Miranta, et al.
Publicado: (2018)

Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size
por: Antoniou, Miranta, et al.
Publicado: (2017)

Time-dependent ROC curve analysis in medical research: current methods and applications
por: Kamarudin, Adina Najwa, et al.
Publicado: (2017)

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
por: Antoniou, Miranta, et al.
Publicado: (2017)

A review of the handling of missing longitudinal outcome data in clinical trials
por: Powney, Matthew, et al.
Publicado: (2014)

Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues
por: Hickey, Graeme L., et al.
Publicado: (2016)

Investigation of 2‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2017)

joineRML: a joint model and software package for time-to-event and multivariate longitudinal outcomes
por: Hickey, Graeme L., et al.
Publicado: (2018)

Investigation of one‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2018)

Bayesian joint modelling of longitudinal and time to event data: a methodological review
por: Alsefri, Maha, et al.
Publicado: (2020)

Spatial and spatio-temporal statistical analyses of retinal images: a review of methods and applications
por: Zhu, Wenyue, et al.
Publicado: (2020)

Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
por: Lee, Chen-Hsiang, et al.
Publicado: (2018)

Assessment and clinical course of hypocalcemia in critical illness
por: Steele, Tom, et al.
Publicado: (2013)

Adjusting for treatment changes in epilepsy: causal analysis of randomised controlled trial survival outcomes in the presence of departure from randomised treatment
por: Dodd, Susanna, et al.
Publicado: (2013)

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Assessing the potential for outcome reporting bias in a review: a tutorial
por: Dwan, Kerry, et al.
Publicado: (2010)

The role of fosfomycin in osteoarticular infection
por: Morata, Laura, et al.
Publicado: (2019)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Spatial Linear Mixed Effects Modelling for OCT Images: SLME Model †
por: Zhu, Wenyue, et al.
Publicado: (2020)

Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review
por: Stevens, David, et al.
Publicado: (2021)

Anthropometric Variables Accurately Predict Dual Energy X-Ray Absorptiometric-Derived Body Composition and Can Be Used to Screen for Diabetes
por: Yavari, Reza, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s05kgdh8k0g4ee7baa6lnqjrb5